Role of miR-490-3p in blocking bladder cancer growth through targeting the RNA-binding protein PCBP2

Cun-Ming Zhang1, Li-De Song2, Jun-Wei Wang1

  • 1Department of Urinary Surgery, The Affiliated Wenling Hospital of Wenzhou Medical University, Taizhou, Zhejiang Province, China.

Insights

MicroRNA-490-3p (miR-490-3p) acts as a tumor suppressor in bladder cancer by inhibiting cell viability and proliferation. Upregulating miR-490-3p suppressed tumor growth in vivo by downregulating PCBP2 expression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNA-490-3p (miR-490-3p) is recognized as a tumor suppressor in various cancers.
  • Its specific role in bladder cancer development and progression is not yet fully elucidated.

Purpose of the Study:

  • To investigate the function of miR-490-3p in bladder cancer.
  • To determine the relationship between miR-490-3p and PCBP2 in bladder cancer regulation.

Main Methods:

  • Cell viability, proliferation, and cell cycle were assessed using CCK-8, BrdU detection, and flow cytometry.
  • In vivo studies involved overexpressing miR-490-3p in bladder cancer cells via lentivirus transfection in BALB/c nude mice.
  • Tumor volume changes were monitored to evaluate the effect of miR-490-3p.

Main Results:

  • miR-490-3p expression was found to be decreased in bladder cancer cells.
  • Overexpression of miR-490-3p significantly inhibited bladder cancer cell viability, proliferation, and induced cell cycle arrest.
  • The tumor suppressor role of miR-490-3p was linked to the downregulation of PCBP2 expression, which could counteract its inhibitory effects.
  • In vivo experiments demonstrated that miR-490-3p upregulation effectively blocked bladder cancer growth in mice.

Conclusions:

  • miR-490-3p functions as a tumor suppressor in bladder cancer.
  • miR-490-3p inhibits bladder cancer cell growth and proliferation, partly by downregulating PCBP2 expression.
  • Targeting miR-490-3p or its downstream effectors may offer therapeutic strategies for bladder cancer.